Tamiflu oral suspension: concentration changed

The concentration of Tamiflu (oseltamivir) oral suspension has changed from 12mg per ml to 6mg per ml, with consequent changes in the dosing instructions.

Tamiflu is licensed for the treatment and prevention of influenza when the virus is circulating in the community. | SCIENCE PHOTO LIBRARY
Tamiflu is licensed for the treatment and prevention of influenza when the virus is circulating in the community. | SCIENCE PHOTO LIBRARY
The dispenser supplied with the revised product will measure in millilitres rather than in milligrams and Roche advises that all prescriptions for Tamiflu oral suspension should now state the dose in millilitres. Patients and parents/carers of children should be carefully advised of the changes.

Interim measures

Supplies of the old presentation expired at the end of July and stocks of the new 6mg per ml presentation are expected to become available in early October. Should the product be required in the interim period, Roche directs prescribers to sections 4.2 and 6.6 of the SPCs for Tamiflu Capsules, which describe the preparation of suitable dosage forms when the powder for suspension is unavailable.

Tamiflu is licensed for the treatment and prevention of influenza when the virus is circulating in the community.

View Tamiflu drug record

Further information: Roche

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in